Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × rezivertinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 293 Radiotherapy 229 Fluorouracil 201 Cyclophosphamide 191 Capecitabine 180 Docetaxel 166 Gemcitabine 164 Oxaliplatin 161 Carboplatin 160 Paclitaxel 152 Leucovorin 122 Drug Therapy 118 Dexamethasone 118 Doxorubicin 112 Etoposide 99 Bevacizumab 90 Cytarabine 86 Vincristine 83 Irinotecan 81 Rituximab 77 Epirubicin 71 Prednisone 65 Methotrexate 62 Radiosurgery 61 Surgical Procedures, Operative 60 Radiation 59 Radiotherapy, Intensity-Modulated 56 Neoadjuvant Therapy 52 Lenalidomide 52 Letrozole 50

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06955325 2025-05-06

UPLIFT

The First Affiliated Hospital of Guangzhou Medical University

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡